A UPLC method development and validation study of Upadacitinib and its impurities in extended – release oral tablet dosage forms

Nimmagadda, Rajya Lakshmi; Gummadi, Sowjanya

doi:10.1016/j.pharma.2024.03.007

Annales Pharmaceutiques Françaises

2024

DOI: 10.1016/j.pharma.2024.03.007

|View full text |Cite

A UPLC method development and validation study of Upadacitinib and its impurities in extended – release oral tablet dosage forms

Rajya Lakshmi Nimmagadda,

Sowjanya Gummadi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Separation and characterization of degradation impurities of upadacitinib by liquid chromatography and high resolution mass spectrometry

Chaganti,

Nelapati,

Jain

et al. 2024

Journal of Chromatography B

View full text Add to dashboard Cite

Separation and characterization of degradation impurities of upadacitinib by liquid chromatography and high resolution mass spectrometry

Chaganti,

Nelapati,

Jain

et al. 2024

Journal of Chromatography B

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A UPLC method development and validation study of Upadacitinib and its impurities in extended – release oral tablet dosage forms

Cited by 1 publication

References 5 publications

Separation and characterization of degradation impurities of upadacitinib by liquid chromatography and high resolution mass spectrometry

Separation and characterization of degradation impurities of upadacitinib by liquid chromatography and high resolution mass spectrometry

Contact Info

Product

Resources

About